Bloomin’ Brands’ stock slides as revenue falls short for a sixth straight quarter

• Trump’s ‘DJT’ stock falls for seventh straight trading session

  Trump Media & Technology Group Corp.’s stock fell for its seventh trading session in a row, as worries about inflation and consumer strength continued to weigh on the broad market.
  
  MarketWatch - 1d

• Instacart stock falls as profit forecast comes up short

  Shares of Instacart fell after hours on Tuesday, after the grocery delivery app’s forecast for its preferred measure of profit came in below expectations.
  
  MarketWatch - 16h

• Shares of world's largest brewer AB InBev pop 9% after posting fourth-quarter revenue beat even as volumes slide

  The drinks maker, whose brands include Budweiser, Corona and Stella Artois, reported an 3.4% increase in fourth-quarter revenue to $14.84 billion.
  
  CNBC - 34m

• Block shares fall on profit, revenue miss

  Block, formerly known as Square, got off to a sluggish start on Wall Street this year after underperforming the Nasdaq in 2024.
  
  CNBC - 5d
• 

  UK budget surplus for January falls short of expectations

  Figures come as chancellor struggles to revive the economy, with business survey showing activity is stalling
  
  Financial Times - 5d

• Workday beats estimates for revenue and profit, stock jumps

  Workday exceeded analysts' estimates for the quarter and pointed to stronger demand from artificial intelligence products.
  
  CNBC - 18h
• 

  Spain wine export revenue rises in 2024 but volumes fall

  Yahoo News - 1d
• 

  Gucci’s Fall Collection Shows Why the Brand Needs a Designer

  It’s time for the brand to take some risks.
  
  The New York Times - 9h
• 

  UK ‘falling short’ in fight against rise of superbugs resistant to antibiotics

  Antimicrobial resistance contributing to estimated 35,000 deaths a year in UK, and government ‘a long way’ from containing the problem, says NAO. Superbugs are on the rise in the UK and the ...
  
  The Guardian - 12h

More from MarketWatch

• Can Nvidia earnings rally the stock market and stop the bleeding in tech?

  Highflying “Magnificent Seven” tech stock are in correction territory. Investors are watching Nvidia’s results to assess tech exposure.
  
  MarketWatch - 15m

• Taser maker Axon brushes off DOGE budget-cut worries as stock rallies

  The company is playing up up its prospects for international growth and its cloud-services business
  
  MarketWatch - 20m

• Eli Lilly to spend $27 billion to expand U.S. manufacturing with four new sites

  Eli Lilly & Co.’s stock rose 1.6% Wednesday, after the drug company announced plans to expand its U.S. manufacturing sites by adding four more locations this year, along with 13,000 high-wage jobs.
  
  MarketWatch - 23m

• T.J. Maxx parent sees broad sales grow, as demand from all income groups rose

  Full-year outlook was below current expectations, as it assumes a ‘small negative impact’ from China tariffs.
  
  MarketWatch - 27m

• Lumen’s stock got little love from Wall Street analysts. That’s now changing.

  Lumen’s stock is rising after a bullish upgrade at Citi. Analysts have hesitated to recommend the telecommunications shares.
  
  MarketWatch - 41m

More in Business

• Can Nvidia earnings rally the stock market and stop the bleeding in tech?

  Highflying “Magnificent Seven” tech stock are in correction territory. Investors are watching Nvidia’s results to assess tech exposure.
  
  MarketWatch - 15m

• Nvidia reports fourth-quarter earnings after the bell

  Nvidia's earnings report on Wednesday will put the finishing touches on one of the most remarkable years from a large company ever.
  
  CNBC - 16m

• AppLovin shares tumble 13% as short sellers question its centerpiece AXON ad software

  Short seller Fuzzy Panda alleged that the AXON model was "the nexus of a House of Cards" built on fraudulent advertising tactics.
  
  CNBC - 17m

• Taser maker Axon brushes off DOGE budget-cut worries as stock rallies

  The company is playing up up its prospects for international growth and its cloud-services business
  
  MarketWatch - 20m

• Eli Lilly to spend $27 billion to expand U.S. manufacturing with four new sites

  Eli Lilly & Co.’s stock rose 1.6% Wednesday, after the drug company announced plans to expand its U.S. manufacturing sites by adding four more locations this year, along with 13,000 high-wage jobs.
  
  MarketWatch - 23m